ICD-10-CM 2027
ICD-10 code for antineoplastic chemotherapy induced pancytopenia
Antineoplastic chemotherapy induced pancytopenia
From the official ICD-10-CM alphabetic index entry “Pancytopenia (acquired) › antineoplastic chemotherapy induced”. Page updated September 29, 2026.
About coding antineoplastic chemotherapy induced pancytopenia
The ICD-10-CM code for antineoplastic chemotherapy induced pancytopenia is D61.810 (Antineoplastic chemotherapy induced pancytopenia).
Within D61.81 (pancytopenia), D61.810 is specifically for antineoplastic chemotherapy induced pancytopenia. Related codes cover other drug-induced pancytopenia (D61.811) and other pancytopenia (D61.818).
The conditions in its Excludes2 note aren't part of D61.810, but may be coded alongside it if the patient has both: aplastic anemia due to antineoplastic chemotherapy (D61.1).
As a secondary diagnosis it is an MCC (major complication or comorbidity), which can move an inpatient stay into the highest-paying "with MCC" MS-DRG of its family, unless the principal diagnosis excludes it.
Common questions about antineoplastic chemotherapy induced pancytopenia ICD-10 codes
What is the ICD-10 code for antineoplastic chemotherapy induced pancytopenia?
- D61.810 — Antineoplastic chemotherapy induced pancytopenia.
Is D61.810 billable?
- Yes. D61.810 is a billable/specific ICD-10-CM code valid for FY2027 (October 1, 2026 – September 30, 2027).
Can D61.810 be used as a principal diagnosis?
- Yes. The Medicare Code Editor doesn't restrict D61.810 as a principal diagnosis.
Is D61.810 a CC or MCC?
- D61.810 is an MCC (major complication or comorbidity) under MS-DRG v44.0, unless excluded by the principal diagnosis.